Quantum BioPharma Ltd.

What they do

The company is registered in Ontario, Canada, at 1 Adelaide Street East, Suite 801, Toronto, and operates under SIC code 2834, Pharmaceutical Preparations. It files as a foreign private issuer on Form 20-F, with its Class B Subordinate Voting Shares registered on the Nasdaq Stock Market LLC. Filings indicate it is not a shell company and is a non-accelerated filer or emerging growth company.

Revenue drivers

• Pharmaceutical preparations — The company's SIC classification is Pharmaceutical Preparations, but the excerpts do not disclose specific products, segments or revenue figures.
• Not disclosed in excerpts — No product lines, customers or revenue-generating activities are named in the supplied source material.

Recent performance

The 20-F was filed for the fiscal year ended December 31, 2025, on March 26, 2026. No revenue, earnings or financial performance figures are included in the filing excerpts provided. Outstanding shares as of December 31, 2025, were 42 Class A Multiple Voting Shares and 3,887,729 Class B Subordinate Voting Shares.

Strategy

The filing excerpts do not describe any specific strategic direction, investments, or priorities. No business development, pipeline or partnership details are provided. The company's executive offices are in Toronto, Ontario, and its CEO is Zeeshan Saeed, who is also Co-Executive Chairman. No forward-looking strategy is stated in the source material.

Risks

• Limited public float and share class structure — With only 3,887,729 Class B shares outstanding and 42 Class A multiple voting shares, liquidity may be constrained and voting control concentrated.
• Foreign private issuer status — As a Canadian issuer filing on Form 20-F, the company is subject to different disclosure and governance requirements than U.S. domestic issuers.
• No disclosed revenue or products — The excerpts do not identify any marketed products, revenue or clinical pipeline, raising uncertainty about the company's commercial operations.
• Nasdaq listing — The Class B shares are listed on Nasdaq under QNTM; the excerpts do not include any compliance or delisting information.

Outlook

The source excerpts contain no management outlook, guidance or forward-looking statements. No future-oriented financial information is included. The filing's cautionary note regarding future oriented financial information is referenced in the table of contents but not provided in the excerpts.